Prosecution Insights
Last updated: October 02, 2026

Examiner: HABTE, KAHSAY

Tech Center 4100 • Art Units: 1624 1626 4100

This examiner grants 85% of resolved cases

Performance Statistics

85.0%
Allow Rate
+25.0% vs TC avg
1,659
Total Applications
+7.4%
Interview Lift
626
Avg Prosecution Days
Based on 1630 resolved cases, 2023–2026

Rejection Statute Breakdown

3.3%
§101 Eligibility
17.0%
§102 Novelty
6.3%
§103 Obviousness
50.7%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18122780 BICYCLIC COMPOUND AND USE THEREOF Non-Final OA SK BIOPHARMACEUTICALS CO., LTD.
18726155 NITROGEN-CONTAINING HETEROCYCLIC COMPOUND HAVING NRF2 ACTIVATION EFFECT Non-Final OA CHUGAI SEIYAKU KABUSHIKI KAISHA
18579949 METHOD FOR PRODUCING ARYLAMIDE DERIVATIVE Non-Final OA CHUGAI SEIYAKU KABUSHIKI KAISHA
18632761 PAN-CASPASE INHIBITORS Final Rejection GEORGE MASON UNIVERSITY
18546087 BICYCLIC TETRAHYDROAZEPINE DERIVATIVES FOR THE TREATMENT OF CANCER Non-Final OA Hoffmann-La Roche Inc.
18683412 PRODRUGS FOR USE IN THE TREATMENT OF TISSUE DAMAGE Non-Final OA UCL BUSINESS LTD
18293171 PHOTOACTIVATABLE PRODRUG NANOPARTICLES FOR COMBINED ANTI-ANGIOGENESIS AND PHOTODYNAMIC THERAPY Non-Final OA The University of Hong Kong
18712407 COMPOUND CONTAINING CYCLOALKYL OR HALOALKYL Non-Final OA CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
18554199 THERAPEUTIC MODALITIES FOR INHIBITING PANCREATIC BETA CELL IMPAIRMENT AND TREATING DIABETES Final Rejection Yissum Research Development Company of The Hebrew University of Jerusalem Ltd.
18335345 Acesulfame Potassium Compositions and Processes for Producing Same Final Rejection Celanese International Corporation
18335325 Acesulfame Potassium Compositions and Processes for Producing Same Final Rejection Celanese International Corporation
18335285 Acesulfame Potassium Compositions and Processes for Producing Same Final Rejection Celanese International Corporation
18335296 Acesulfame Potassium Compositions and Processes for Producing Same Final Rejection Celanese International Corporation

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month